COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,037 Articles (22,627 medRxiv, 8,410 bioRxiv)

Most recent first Previous |  Page 256: Articles 2551-2560  | Next

Symptoms of children and adolescents infected with SARS-CoV-2 variants alpha, delta or omicron
Schulze, H., Bayer, W.
10.1101/2024.01.07.23300006 — Posted: 2024-01-09
How executive control and emotional reactivity influence coping strategies in psychiatric patients during the COVID-19 pandemic
Kist, J. D., Schlüter, L., Duyser, F., Mulders, P. C. R., Vrijsen, J. N., Collard, R. M., van Eijndhoven, P., Tendolkar, I.
10.1101/2024.01.08.24300980 — Posted: 2024-01-09
Preferential apical infection of intestinal cell monolayers by SARS-CoV-2 is associated with damage to cellular barrier integrity: Implications for the physiopathology of COVID-19
Clemence, G., Jeffrey, A., Jonatane, A., Mege, J.-L., Omar Osman, I., Devaux, C. A.
10.1101/2024.01.08.574642 — Posted: 2024-01-09
Efficient overexpression and purification of SARS-CoV-2 Nucleocapsid proteins in Escherichia coli
Brudenell, E. L., Pohare, M. B., Zafred, D., Phipps, J., Hornsby, H. R., Darby, J., Dai, J., Liggett, E., Cain, K., Barran, P. E., de Silva, T. I., Sayers, J. R.
10.1101/2024.01.08.574531 — Posted: 2024-01-09
Human bronchopulmonary disposition and plasma pharmacokinetics of oral bemnifosbuvir (AT-527), an experimental guanosine nucleotide prodrug for COVID-19
Zhou, X.-J., Horga, A., Puri, A., Winchester, L., Montrond, M., Pietropaolo, K., Belanger, B., Fletcher, C. V., Hammond, J.
10.1101/2024.01.03.24300783 — Posted: 2024-01-08
A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models
Puray-Chavez, M., LaPak, K., Jasuja, R., Pan, J., Xu, J., Eschbach, J. E., Mohammed, S., Lawson, D., Wang, Q., Brody, S. L., Major, M. B., Goldfarb, D., Kutluay, S. B.
10.1101/2024.01.07.574522 — Posted: 2024-01-08
Towards Real-Time Airborne Pathogen Sensing: Electrostatic Capture and On-Chip LAMP Based Detection of Airborne Viral Pathogens
Jaykumar, N. S., Caffrey, V., Paprotny, I., Caffrey, M.
10.1101/2024.01.05.574431 — Posted: 2024-01-08
GENOMIC PROFILING OF SARS-COV-2 STRAINS CIRCULATING IN SOUTH EASTERN REGION OF INDIA DURING THREE WAVES OF PANDEMIC
Kandhasamy, V., Balakrishna Pillai, A., Mariappan, V., Ramalingam, M., Raganadin, P., Ramadoss, R., Moovarkumudalvan, B., Easow, J. M., Vasudevan, M., S.R., R.
10.1101/2024.01.06.574128 — Posted: 2024-01-08
Innate Immune Activation and Mitochondrial ROS Invoke Persistent Cardiac Conduction System Dysfunction after COVID-19
Ashok, D., Liu, T., Criscione, J., Prakash, M., Kim, B., Chow, J., Craney, M., Papanicolaou, K., Sidor, A., Foster, D. B., Pekosz, A., Villano, J., Kim, D.-H., O'Rourke, B.
10.1101/2024.01.05.574280 — Posted: 2024-01-08
The kinetics of SARS-CoV-2 nsp7-11 polyprotein processing and impact on complexation with nsp16
Schamoni-Kast, K., Krichel, B., Damjanovic, T., Kierspel, T., Toker, S., Uetrecht, C.
10.1101/2024.01.06.574466 — Posted: 2024-01-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).